Category: elsevier

Researchers repeat retracted study, republish in same journal sans first author

biol psychWe’ve been following the case of Amine Bahi, a neuroscience researcher in the United Arab Emirates who has managed something unusual in the annals of Retraction Watch: Three different retractions for three completely different reasons. One was for “legal issues,” another was for lack of IRB approval, and the third was for using RNAs from the wrong species.

Now, Bahi’s co-authors have repeated the last of those studies with the right RNAs, and have republished their paper in the same journal, Biological Psychiatry — but without Bahi.

The retraction notice for “Blockade of Protein Phosphatase 2B Activity in the Amygdala Increases Anxiety- and Depression-Like Behaviors in Mice” now includes this final paragraph: Continue reading Researchers repeat retracted study, republish in same journal sans first author

Oncology researcher Getzenberg notches seventh retraction

GetzenbergRobert Getzenberg, a former Hopkins and Pitt cancer researcher, has retracted another paper, his seventh.

Here’s the notice for “Highly specific urine-based marker of bladder cancer,” a paper first published in Urology in 2005: Continue reading Oncology researcher Getzenberg notches seventh retraction

Forged authorship sinks melanoma paper

ijbcbThe International Journal of Biochemistry & Cell Biology has retracted a 2013 paper by a group from China after learning that only the first author knew about the article.

The paper was titled “Construction of circular miRNA sponges targeting miR-21 or miR-221 and demonstration of their excellent anticancer effects on malignant melanoma cells,” and it was led by Yuchen Liu. Liu’s affiliations include the Institute of Dermatology and Department of Dermatology at No. 1 Hospital, part of Anhui Medical University, and the State Key Laboratory Incubation Base of Dermatology for the Ministry of National Science and Technology.

Here’s the retraction notice:
Continue reading Forged authorship sinks melanoma paper

Sampling error, flawed analysis, and miscalculation trigger Molecular Cell retraction

molecular cell 14Guest post by Jean Hazel Mendoza

A group of researchers from France has retracted a 2013 paper from Molecular Cell after realizing that their analyses of microscopy images were flawed.

Here’s the notice for “RecA-Promoted, RecFOR-Independent Progressive Disassembly of Replisomes Stalled by Helicase Inactivation:” Continue reading Sampling error, flawed analysis, and miscalculation trigger Molecular Cell retraction

“Gremlins” caused errors in climate change paper showing gains from global warming

jep_coverThe author of a controversial 2009 paper arguing that at least some amount of global warming could lead to economic gains has corrected the paper, along with a later article in a different journal. We confess to be baffled by the implications of the mix-up, although others appear to be less confused.

The 2009 article, “The Economic Effects of Climate Change,” was written by Richard Tol, of the University of Sussex, and appeared in the Journal of Economic Perspectives. It has been cited 91 times, according to Thomson Scientific’s Web of Science.

Here’s the abstract:

Continue reading “Gremlins” caused errors in climate change paper showing gains from global warming

Nothing to see here: Unreplicable eye paper ends in retraction

jneuroimmunoThe authors of a 2012 paper in the Journal of Neuroimmunology have retracted the paper after some of the researchers were unable to verify the findings in follow-up work.

The article, “Association of transforming growth factor beta-1 (TGFB1) regulatory region polymorphisms with myasthenia gravis-related ophthalmoparesis,” came from a lab at Groote Schuur Hospital and the University of Cape Town, in South Africa.

According to the abstract: Continue reading Nothing to see here: Unreplicable eye paper ends in retraction

Seventh retraction appears for author who tampered with investigation

bioorganicsKarel Bezouška, who tried tampering with an investigation into his work by breaking into a lab refrigerator, has had a seventh paper retracted.

Here’s the notice for “Carboxylated calixarenes bind strongly to CD69 and protect CD69+ killer cells from suicidal cell death induced by tumor cell surface ligands,” which was first published in Bioorganic & Medicinal Chemistry in 2010: Continue reading Seventh retraction appears for author who tampered with investigation

Paper claiming a way to “print any drug instantly” gets unprinted

ddtA recent paper proposing a way to “print any drug instantly” has been withdrawn by the author, following bewildered reactions from the blogosphere.

The paper made the rounds at various chemistry-focused blogs last month. Derek Lowe of In The Pipeline picked up on it too, calling the article

one of the oddest papers to appear in Drug Discovery Today, which is saying something.

Apparently, the author — or someone claiming to be the author, using the initials YC — wasn’t crazy about the criticism. He left this comment on In The Pipeline and elsewhere: Continue reading Paper claiming a way to “print any drug instantly” gets unprinted

Shigeaki Kato up to 25 retractions

Shigeaki Kato
Shigeaki Kato

Shigeaki Kato, who resigned from the University of Tokyo in 2012 after being found to have inappropriately manipulated dozens of images, has two more retractions, both in Molecular Cell.

Here’s the notice for 2002’s “Nuclear Receptor Function Requires a TFTC-Type Histone Acetyl Transferase Complex:” Continue reading Shigeaki Kato up to 25 retractions

Did article on doped indium contain a doped image?

asscoverApplied Surface Science has retracted a 2010 paper by a group of researchers from India and Brazil because one of the figures in the article was suspect.

The paper was titled “Effect of hydrogenation vs. re-heating on intrinsic magnetization of Co doped In2O3.”

Continue reading Did article on doped indium contain a doped image?